---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-001345"
form_type: "8-K/A"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2022-02-25T23:59:59+00:00"
generated_at: "2026-06-27T04:13:17.251422+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Joint Corp. reports 38% revenue growth in FY2021; corrects 2022 clinic opening guidance to 110-130

## Summary
- Q4 revenue $22.4M (+32% YoY); net income $224K vs $10.6M (prior year benefitted from $8.9M tax valuation allowance reversal).
- Full-year revenue $81.2M (+38%); Adjusted EBITDA $13.3M (+46%); system-wide comp sales +29%.
- Opened 130 clinics in 2021 (110 franchised, 20 greenfield); total clinics 706 at year-end.
- 2022 guidance: revenue $102-106M, Adjusted EBITDA $15-17M; franchised openings corrected to 110-130 from 130-140.
- Cash $19.5M at Dec 31, 2021; sold 156 franchise licenses in 2021 vs 121 in 2020.

## SEC filing metadata
- accession: 0001171843-22-001345
- form_type: 8-K/A
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2022-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000117184322001345/0001171843-22-001345-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000117184322001345/f8ka_022522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-001345
- JSON: https://secwatch.observer/filing/0001171843-22-001345.json
- Plain text: https://secwatch.observer/filing/0001171843-22-001345.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.